Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Share-based Compensation (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Share-based Compensation data on record, last reported at $1.5 million in Q4 2024.

  • For Q4 2024, Share-based Compensation rose 17.01% year-over-year to $1.5 million; the TTM value through Dec 2024 reached $5.3 million, up 5.97%, while the annual FY2025 figure was $6.4 million, 21.96% up from the prior year.
  • Share-based Compensation reached $1.5 million in Q4 2024 per SGMT's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.9 million in Q3 2023 and bottomed at $759000.0 in Q1 2024.